Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA is a research paper published in EP Europace (2022). On theSindex it has a DataRank of 1.2. It has been cited 36 times, with 32 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0.632
From 23 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 32 citers.
United States National Institutes of Health (NIH) grants
Grant: U01HL089709
United States National Institutes of Health (NIH) grants
Grant: U01HL089786
United States National Institutes of Health (NIH) grants
Grant: U01HL089907
United States National Institutes of Health (NIH) grants
Grant: U01HL089645
National Institutes of Health
Grant: 5U01HL089907-04
CABANA EQOL Trial
National Institutes of Health
Grant: 5U01HL089645-05
Cabana Image Analysis Lab
National Institutes of Health
Grant: 5U01HL089786-05
CABANA-AF Trial
National Institutes of Health
Grant: 5U01HL089709-02
Catheter Ablation versus Antiarrythmic Drug Therapy for Atrial Fibrilllation Tria
Fields of Study
Keywords
Sustainable Development Goals